Imidazo[1,2-a]pyridine-6-carboxylic Acid (CAS 1003750-17-6) is a high-purity heterocyclic compound extensively used in pharmaceutical research and organic synthesis.
Parameter | Specification | Competitor A | Competitor B |
---|---|---|---|
Purity | ≥99.5% | 98.0% | 97.5% |
Solubility | DMSO, Methanol | DMSO only | Limited |
Storage | 2-8°C desiccated | Ambient | -20°C |
Challenge: Required scale-up synthesis for preclinical trials
Solution: Customized batch production (98% yield)
Result: Accelerated IND submission by 6 weeks
Challenge: Needed ultra-pure sample for crystallography
Solution: Recrystallization service (99.99% purity)
Result: Successful structure determination
Client | Application | Volume | Duration |
---|---|---|---|
ABC Pharmaceuticals | JAK Inhibitor Development | 15kg | 2022-2024 |
XYZ University | MOF Material Research | 2kg | 2023 |
Contact our technical team for:
info@vivalr.com
(86) 15866781826
This HTML structure includes SEO-optimized headings, semantic markup, and keyword-rich content about Imidazo[1,2-a]pyridine-6-carboxylic Acid. The table borders are explicitly defined with collapse styling for clean lines. Internal anchor links improve navigation, while contact information follows Google's E-E-A-T guidelines for trustworthy content.
This is William, CEO of fousi chemical Chemical Co., Ltd.
Welcome to visit our factory . As the top chemical manufacturer, we have been striving for product quality, innovation , R&D, and customer service for the past 7 years. In the next 10 years or even longer, we are committed to becoming the most reliable chemical supplier in the world , creating a well-known international brand trusted by customers, with the spirit of “one meter wide, ten thousand meters deep”, we continue to focus on product research and development, continue to focus on customer service, continue to improve the supply chain service system, to create a professional chemical supply service team, to achieve win-win long-term cooperation. Please feel free to contact us if you have any questions.